{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T23:14:33Z","timestamp":1791328473167,"version":"4.3.1"},"reference-count":49,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,11,1]],"date-time":"2016-11-01T00:00:00Z","timestamp":1477958400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100004099","name":"Ligue contre le Cancer","doi-asserted-by":"publisher","award":["FI10549MWHJ"],"award-info":[{"award-number":["FI10549MWHJ"]}],"id":[{"id":"10.13039\/501100004099","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Alsace contre le Cancer"},{"DOI":"10.13039\/501100004794","name":"Centre National de la Recherche Scientifique","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004794","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003768","name":"Universit\u00e9 de Strasbourg","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003768","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochimie"],"published-print":{"date-parts":[[2016,11]]},"DOI":"10.1016\/j.biochi.2016.07.003","type":"journal-article","created":{"date-parts":[[2016,7,16]],"date-time":"2016-07-16T09:58:43Z","timestamp":1468663123000},"page":"14-22","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"special_numbering":"C","title":["Liposomal constructs for antitumoral vaccination by the nasal route"],"prefix":"10.1016","volume":"130","author":[{"given":"Zahra","family":"Kakhi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beno\u00eet","family":"Frisch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B\u00e9atrice","family":"Heurtault","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fran\u00e7oise","family":"Pons","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.biochi.2016.07.003_bib1","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1038\/nri3251","article-title":"Recent progress in mucosal vaccine development: potential and limitations","volume":"12","author":"Lycke","year":"2012","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.biochi.2016.07.003_bib2","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.vaccine.2011.11.003","article-title":"New insights in mucosal vaccine development","volume":"30","author":"Pavot","year":"2012","journal-title":"Vaccine"},{"key":"10.1016\/j.biochi.2016.07.003_bib3","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1146\/annurev-bioeng-071811-150054","article-title":"Mucosal vaccine design and delivery","volume":"14","author":"Woodrow","year":"2012","journal-title":"Annu. Rev. Biomed. Eng."},{"key":"10.1016\/j.biochi.2016.07.003_bib4","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.1164\/rccm.201011-1783OC","article-title":"Potential of nasopharynx-associated lymphoid tissue for vaccine responses in the airways","volume":"183","author":"Brandtzaeg","year":"2011","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.biochi.2016.07.003_bib5","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1165\/rcmb.2010-0152RT","article-title":"Bronchus-associated lymphoid tissue: an entry site for antigens for successful mucosal vaccinations?","volume":"43","author":"Pabst","year":"2010","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"10.1016\/j.biochi.2016.07.003_bib6","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1016\/j.vaccine.2009.11.021","article-title":"Intranasal immunization with vaccine vector Streptococcus gordonii elicits primed CD4+ and CD8+ T cells in the genital and intestinal tracts","volume":"28","author":"Ciabattini","year":"2010","journal-title":"Vaccine"},{"key":"10.1016\/j.biochi.2016.07.003_bib7","doi-asserted-by":"crossref","first-page":"2725","DOI":"10.1128\/IAI.70.5.2725-2729.2002","article-title":"Intravaginal and intranasal immunizations are equally effective in inducing vaginal antibodies and conferring protection against vaginal candidiasis","volume":"70","author":"De Bernardis","year":"2002","journal-title":"Infect. Immun."},{"key":"10.1016\/j.biochi.2016.07.003_bib8","doi-asserted-by":"crossref","first-page":"172ra20","DOI":"10.1126\/scitranslmed.3004888","article-title":"Mucosal imprinting of vaccine-induced CD8(+) T cells is crucial to inhibit the growth of mucosal tumors","volume":"5","author":"Sandoval","year":"2013","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.biochi.2016.07.003_bib9","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/j.addr.2004.10.001","article-title":"Need for new vaccine formulations and potential of particulate antigen and DNA delivery systems","volume":"57","author":"Friede","year":"2005","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.biochi.2016.07.003_bib10","doi-asserted-by":"crossref","first-page":"515","DOI":"10.3390\/vaccines2030515","article-title":"Peptide vaccine: progress and challenges","volume":"2","author":"Li","year":"2014","journal-title":"Vaccines (Basel)"},{"key":"10.1016\/j.biochi.2016.07.003_bib11","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1111\/j.1440-1711.2004.01288.x","article-title":"Mucosal adjuvants and delivery systems for protein-, DNA- and RNA-based vaccines","volume":"82","author":"Vajdy","year":"2004","journal-title":"Immunol. Cell Biol."},{"key":"10.1016\/j.biochi.2016.07.003_bib12","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1177\/2051013614541440","article-title":"Liposomes as vaccine delivery systems: a review of the recent advances","volume":"2","author":"Schwendener","year":"2014","journal-title":"Ther. Adv. Vaccines"},{"key":"10.1016\/j.biochi.2016.07.003_bib13","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1007\/s11095-008-9724-y","article-title":"Design of a liposomal candidate vaccine against Pseudomonas aeruginosa and its evaluation in triggering systemic and lung mucosal immunity","volume":"26","author":"Heurtault","year":"2009","journal-title":"Pharm. Res."},{"key":"10.1016\/j.biochi.2016.07.003_bib14","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1016\/j.ijpharm.2015.11.027","article-title":"Airway administration of a highly versatile peptide-based liposomal construct for local and distant antitumoral vaccination","volume":"496","author":"Kakhi","year":"2015","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.biochi.2016.07.003_bib15","doi-asserted-by":"crossref","first-page":"3123","DOI":"10.1016\/S0264-410X(02)00261-X","article-title":"Intranasal administration of a synthetic peptide vaccine encapsulated in liposome together with an anti-CD40 antibody induces protective immunity against influenza A virus in mice","volume":"20","author":"Ninomiya","year":"2002","journal-title":"Vaccine"},{"key":"10.1016\/j.biochi.2016.07.003_bib16","doi-asserted-by":"crossref","first-page":"5128","DOI":"10.1038\/srep05128","article-title":"Intranasal mRNA nanoparticle vaccination induces prophylactic and therapeutic anti-tumor immunity","volume":"4","author":"Phua","year":"2014","journal-title":"Sci. Rep."},{"key":"10.1016\/j.biochi.2016.07.003_bib17","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1186\/1471-2172-9-38","article-title":"Protection against tuberculosis by a single intranasal administration of DNA-hsp65 vaccine complexed with cationic liposomes","volume":"9","author":"Rosada","year":"2008","journal-title":"BMC Immunol."},{"key":"10.1016\/j.biochi.2016.07.003_bib18","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1128\/CVI.00116-09","article-title":"Highly efficient antiviral CD8+ T-cell induction by peptides coupled to the surfaces of liposomes","volume":"16","author":"Takagi","year":"2009","journal-title":"Clin. Vaccine Immunol."},{"key":"10.1016\/j.biochi.2016.07.003_bib19","doi-asserted-by":"crossref","first-page":"5681","DOI":"10.1016\/j.actbio.2012.11.007","article-title":"Application of galactose-modified liposomes as a potent antigen presenting cell targeted carrier for intranasal immunization","volume":"9","author":"Wang","year":"2013","journal-title":"Acta Biomater."},{"key":"10.1016\/j.biochi.2016.07.003_bib20","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.canlet.2009.05.037","article-title":"Intranasal administration of CpG DNA lipoplex prevents pulmonary metastasis in mice","volume":"287","author":"Zhou","year":"2010","journal-title":"Cancer Lett."},{"key":"10.1016\/j.biochi.2016.07.003_bib21","doi-asserted-by":"crossref","first-page":"L833","DOI":"10.1152\/ajplung.00173.2001","article-title":"Distribution of intranasal instillations in mice: effects of volume, time, body position, and anesthesia","volume":"282","author":"Southam","year":"2002","journal-title":"Am. J. Physiol. Lung Cell Mol. Physiol."},{"key":"10.1016\/j.biochi.2016.07.003_bib22","doi-asserted-by":"crossref","first-page":"3209","DOI":"10.1016\/S0264-410X(02)00247-5","article-title":"Tracking the tissue distribution of marker dye following intranasal delivery in mice and chinchillas: a multifactorial analysis of parameters affecting nasal retention","volume":"20","author":"Visweswaraiah","year":"2002","journal-title":"Vaccine"},{"key":"10.1016\/j.biochi.2016.07.003_bib23","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1517\/17425247.2010.488687","article-title":"Liposomes as delivery systems for nasal vaccination: strategies and outcomes","volume":"7","author":"Heurtault","year":"2010","journal-title":"Expert Opin. Drug Deliv."},{"key":"10.1016\/j.biochi.2016.07.003_bib24","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1021\/bc034184t","article-title":"Synthesis of thiol-reactive lipopeptide adjuvants. Incorporation into liposomes and study of their mitogenic effect on mouse splenocytes","volume":"15","author":"Roth","year":"2004","journal-title":"Bioconjug. Chem."},{"key":"10.1016\/j.biochi.2016.07.003_bib25","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/S0005-2736(97)00177-6","article-title":"Ultraflexible vesicles, Transfersomes, have an extremely low pore penetration resistance and transport therapeutic amounts of insulin across the intact mammalian skin","volume":"1368","author":"Cevc","year":"1998","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.biochi.2016.07.003_bib26","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.addr.2014.05.001","article-title":"Lipid-based carriers for pulmonary products: preclinical development and case studies in humans","volume":"75","author":"Cipolla","year":"2014","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.biochi.2016.07.003_bib27","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1517\/17425240802652309","article-title":"Recent advances in liposomal dry powder formulations: preparation and evaluation","volume":"6","author":"Misra","year":"2009","journal-title":"Expert Opin. Drug Deliv."},{"key":"10.1016\/j.biochi.2016.07.003_bib28","doi-asserted-by":"crossref","first-page":"4574","DOI":"10.1016\/j.biomaterials.2011.03.015","article-title":"Antitumor activity of liposomal ErbB2\/HER2 epitope peptide-based vaccine constructs incorporating TLR agonists and mannose receptor targeting","volume":"32","author":"Thomann","year":"2011","journal-title":"Biomaterials"},{"key":"10.1016\/j.biochi.2016.07.003_bib29","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.ddtec.2005.05.003","article-title":"Vesicles as a tool for transdermal and dermal delivery","volume":"2","author":"Honeywell-Nguyen","year":"2005","journal-title":"Drug Discov. Today Technol."},{"key":"10.1016\/j.biochi.2016.07.003_bib30","first-page":"965280","article-title":"Effect of chemical enhancers in transdermal permeation of alfuzosin hydrochloride","volume":"2012","author":"Prasanthi","year":"2012","journal-title":"ISRN Pharm."},{"key":"10.1016\/j.biochi.2016.07.003_bib31","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1021\/bc990122k","article-title":"Differential reactivity of maleimide and bromoacetyl functions with thiols: application to the preparation of liposomal diepitope constructs","volume":"11","author":"Schelte","year":"2000","journal-title":"Bioconjug. Chem."},{"key":"10.1016\/j.biochi.2016.07.003_bib32","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.vetimm.2011.03.004","article-title":"Mucosal vaccination: lung versus nose","volume":"148","author":"Vujanic","year":"2012","journal-title":"Vet. Immunol. Immunopathol."},{"key":"10.1016\/j.biochi.2016.07.003_bib33","doi-asserted-by":"crossref","first-page":"5179","DOI":"10.1016\/j.vaccine.2010.05.075","article-title":"Nasal associated lymphoid tissue (NALT) contributes little to protection against aerosol challenge with Mycobacterium tuberculosis after immunisation with a recombinant adenoviral vaccine","volume":"28","author":"Ronan","year":"2010","journal-title":"Vaccine"},{"key":"10.1016\/j.biochi.2016.07.003_bib34","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.ymeth.2009.03.027","article-title":"Intranasal administration of proteoliposome-derived cochleates from Vibrio cholerae O1 induce mucosal and systemic immune responses in mice","volume":"49","author":"Acevedo","year":"2009","journal-title":"Methods"},{"key":"10.1016\/j.biochi.2016.07.003_bib35","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1016\/j.vaccine.2009.11.035","article-title":"Intranasal immunization with a proteoliposome-derived cochleate containing recombinant gD protein confers protective immunity against genital herpes in mice","volume":"28","author":"Del Campo","year":"2010","journal-title":"Vaccine"},{"key":"10.1016\/j.biochi.2016.07.003_bib36","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.vaccine.2008.10.052","article-title":"A\u00a0proteoliposome based formulation administered by the nasal route produces vibriocidal antibodies against El Tor Ogawa Vibrio cholerae O1 in BALB\/c mice","volume":"27","author":"Perez","year":"2009","journal-title":"Vaccine"},{"key":"10.1016\/j.biochi.2016.07.003_bib37","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1007\/s11095-005-9078-7","article-title":"Strong mucosal and systemic immunities induced by nasal immunization with anthrax protective antigen protein incorporated in liposome-protamine-DNA particles","volume":"23","author":"Sloat","year":"2006","journal-title":"Pharm. Res."},{"key":"10.1016\/j.biochi.2016.07.003_bib38","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.ejpb.2006.05.005","article-title":"Nasal immunization studies using liposomes loaded with tetanus toxoid and CpG-ODN","volume":"64","author":"Tafaghodi","year":"2006","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.biochi.2016.07.003_bib39","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.ijpharm.2009.10.043","article-title":"CAF01 liposomes as a mucosal vaccine adjuvant: in\u00a0vitro and in\u00a0vivo investigations","volume":"390","author":"Christensen","year":"2010","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.biochi.2016.07.003_bib40","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.ymeth.2006.05.027","article-title":"Liposomal vaccines\u2013targeting the delivery of antigen","volume":"40","author":"Altin","year":"2006","journal-title":"Methods"},{"key":"10.1016\/j.biochi.2016.07.003_bib41","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.jconrel.2012.05.010","article-title":"Targeting tumor antigens to dendritic cells using particulate carriers","volume":"161","author":"Joshi","year":"2012","journal-title":"J.\u00a0Control Release"},{"key":"10.1016\/j.biochi.2016.07.003_bib42","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1002\/eji.200737984","article-title":"Nanoparticles target distinct dendritic cell populations according to their size","volume":"38","author":"Manolova","year":"2008","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.biochi.2016.07.003_bib43","doi-asserted-by":"crossref","first-page":"2256","DOI":"10.1016\/j.vaccine.2012.01.070","article-title":"Design considerations for liposomal vaccines: influence of formulation parameters on antibody and cell-mediated immune responses to liposome associated antigens","volume":"30","author":"Watson","year":"2012","journal-title":"Vaccine"},{"key":"10.1016\/j.biochi.2016.07.003_bib44","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.jconrel.2009.09.018","article-title":"Comparison of liposome based antigen delivery systems for protection against Leishmania donovani","volume":"141","author":"Bhowmick","year":"2010","journal-title":"J.\u00a0Control Release"},{"key":"10.1016\/j.biochi.2016.07.003_bib45","first-page":"1","article-title":"Transfersomes: a promising approach for transdermal drug delivery system","volume":"3","author":"Kumavat","year":"2013","journal-title":"Asian J. Pharm. Sci. Res."},{"key":"10.1016\/j.biochi.2016.07.003_bib46","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1211\/0022357055515","article-title":"Tetanus toxoid-loaded transfersomes for topical immunization","volume":"57","author":"Gupta","year":"2005","journal-title":"J.\u00a0Pharm. Pharmacol."},{"key":"10.1016\/j.biochi.2016.07.003_bib47","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.ijpharm.2004.12.022","article-title":"Non-invasive vaccine delivery in transfersomes, niosomes and liposomes: a comparative study","volume":"293","author":"Gupta","year":"2005","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.biochi.2016.07.003_bib48","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1016\/j.addr.2011.12.009","article-title":"Oral drug delivery with polymeric nanoparticles: the gastrointestinal mucus barriers","volume":"64","author":"Ensign","year":"2012","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.biochi.2016.07.003_bib49","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.addr.2008.11.002","article-title":"Mucus-penetrating nanoparticles for drug and gene delivery to mucosal tissues","volume":"61","author":"Lai","year":"2009","journal-title":"Adv. Drug Deliv. Rev."}],"container-title":["Biochimie"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0300908416301328?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0300908416301328?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,8,9]],"date-time":"2019-08-09T20:44:19Z","timestamp":1565383459000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0300908416301328"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,11]]},"references-count":49,"alternative-id":["S0300908416301328"],"URL":"https:\/\/doi.org\/10.1016\/j.biochi.2016.07.003","relation":{},"ISSN":["0300-9084"],"issn-type":[{"value":"0300-9084","type":"print"}],"subject":[],"published":{"date-parts":[[2016,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Liposomal constructs for antitumoral vaccination by the nasal route","name":"articletitle","label":"Article Title"},{"value":"Biochimie","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biochi.2016.07.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier B.V. and Soci\u00e9t\u00e9 Fran\u00e7aise de Biochimie et Biologie Mol\u00e9culaire (SFBBM). All rights reserved.","name":"copyright","label":"Copyright"}]}}